Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Fenaux, P; Chomienne, C; Degos, L
   Treatment of acute promyelocytic leukaemia
   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
   
   P. Fenaux et al., "Treatment of acute promyelocytic leukaemia", BEST P R C, 14(1), 2001, pp. 153-174
2. Buckstein, RJ; Rimrie, K; Pennell, N; Spaner, D; Hewitt, K; Berinstein, NL
   Prolonged molecular and clinical remission after treatment of a patient with follicular lymphoma with rituximab
   LEUKEMIA & LYMPHOMA
   
   R.J. Buckstein et al., "Prolonged molecular and clinical remission after treatment of a patient with follicular lymphoma with rituximab", LEUK LYMPH, 41(3-4), 2001, pp. 451-455
3. Powell, BL
   Acute progranulocytic leukemia
   CURRENT OPINION IN ONCOLOGY
   
   B.L. Powell, "Acute progranulocytic leukemia", CURR OPIN O, 13(1), 2001, pp. 8-13
4. Jurcic, JG
   Antibody therapy for residual disease in acute myelogenous leukemia
   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
   
   J.G. Jurcic, "Antibody therapy for residual disease in acute myelogenous leukemia", CR R ONC H, 38(1), 2001, pp. 37-45
5. Tabayashi, T; Masuda, K; Yamada, K; Takeuchi, M; Matsue, K
   Successful eradication of residual bcr-abl-positive clones by donor leukocyte transfusion in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia after peripheral blood stem cell transplantation
   INTERNATIONAL JOURNAL OF HEMATOLOGY
   
   T. Tabayashi et al., "Successful eradication of residual bcr-abl-positive clones by donor leukocyte transfusion in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia after peripheral blood stem cell transplantation", INT J HEMAT, 74(3), 2001, pp. 354-356
6. Visani, G; Buonamici, S; Malagola, M; Isidori, A; Piccaluga, PP; Martinelli, G; Ottaviani, E; Grafone, T; Baccarani, M; Tura, S
   Pulsed ATRA as single therapy restores long-term remission in PML-RAR alpha-positive acute promyelocytic leukemia patients: real time quantification of minimal residual disease. A pilot study
   LEUKEMIA
   
   G. Visani et al., "Pulsed ATRA as single therapy restores long-term remission in PML-RAR alpha-positive acute promyelocytic leukemia patients: real time quantification of minimal residual disease. A pilot study", LEUKEMIA, 15(11), 2001, pp. 1696-1700
7. Specchia, G; Lo Coco, F; Vignetti, M; Avvisati, G; Fazi, P; Albano, F; Di Raimondo, F; Martino, B; Ferrara, F; Selleri, C; Liso, V; Mandelli, F
   Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: A report by the Gruppo Italiano Malattie Ematologiche dell'Adulto
   JOURNAL OF CLINICAL ONCOLOGY
   
   G. Specchia et al., "Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: A report by the Gruppo Italiano Malattie Ematologiche dell'Adulto", J CL ONCOL, 19(20), 2001, pp. 4023-4028
8. Hernandez, JM; Martin, G; Gutierrez, NC; Cervera, J; Ferro, MT; Calasanz, MJ; Martinez-Climent, JA; Luno, E; Tormo, M; Rayon, C; Diaz-Mediavilla, J; Gonzalez, M; Gonzalez-San Miguel, JD; Perez-Equiza, K; Rivas, C; Esteve, J; Alvarez, MD; Odriozola, J; Ribera, JM; Sanz, MA
   Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracycline-based protocol. A report from the Spanish group PETHEMA
   HAEMATOLOGICA
   
   J.M. Hernandez et al., "Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracycline-based protocol. A report from the Spanish group PETHEMA", HAEMATOLOG, 86(8), 2001, pp. 807-813
9. Gameiro, P; Vieira, S; Carrara, P; Silva, AL; Diamond, J; de Sousa, AB; Mehta, AB; Prentice, HG; Guimaraes, JE; Hoffbrand, AV; Foroni, L; Parreira, A
   The PML-RAR alpha transcript in long-term follow-up of acute promyelocyticleukemia patients
   HAEMATOLOGICA
   
   P. Gameiro et al., "The PML-RAR alpha transcript in long-term follow-up of acute promyelocyticleukemia patients", HAEMATOLOG, 86(6), 2001, pp. 577-585
10. Tallman, MS
    Arsenic trioxide: its role in acute promyelocytic leukemia and potential in other hematologic malignancies
    BLOOD REVIEWS
    
    M.S. Tallman, "Arsenic trioxide: its role in acute promyelocytic leukemia and potential in other hematologic malignancies", BLOOD REV, 15(3), 2001, pp. 133-142
11. Kumar, S; Chen, MG; Gastineau, DA; Gertz, MA; Inwards, DJ; Lacy, MQ; Tefferi, A; Litzow, MR
    Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemia
    BONE MARROW TRANSPLANTATION
    
    S. Kumar et al., "Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemia", BONE MAR TR, 28(10), 2001, pp. 951-956
12. Avvisati, G; Lo Coco, F; Mandelli, F
    Acute promyelocytic leukemia: Clinical and morphologic features and prognostic factors
    SEMINARS IN HEMATOLOGY
    
    G. Avvisati et al., "Acute promyelocytic leukemia: Clinical and morphologic features and prognostic factors", SEM HEMATOL, 38(1), 2001, pp. 4-12
13. Fenaux, P; Chomienne, C; Degos, L
    All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia
    SEMINARS IN HEMATOLOGY
    
    P. Fenaux et al., "All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia", SEM HEMATOL, 38(1), 2001, pp. 13-25
14. Petti, MC; Pinazzi, MB; Diverio, D; Romano, A; Petrucci, MT; De Santis, S; Meloni, G; Tafuri, A; Mandelli, F; Lo Coco, F
    Prolonged molecular remission in advanced acute promyelocytic leukaemia after treatment with gemtuzumab ozogamicin (Mylotarg (TM) CMA-676)
    BRITISH JOURNAL OF HAEMATOLOGY
    
    M.C. Petti et al., "Prolonged molecular remission in advanced acute promyelocytic leukaemia after treatment with gemtuzumab ozogamicin (Mylotarg (TM) CMA-676)", BR J HAEM, 115(1), 2001, pp. 63-65
15. Jurcic, JG; Nimer, SD; Scheinberg, DA; DeBlasio, T; Warrell, RP; Miller, WH
    Prognostic significance of minimal residual disease detection and PML/RAR-alpha isoform type: long-term follow-up in acute promyelocytic leukemia
    BLOOD
    
    J.G. Jurcic et al., "Prognostic significance of minimal residual disease detection and PML/RAR-alpha isoform type: long-term follow-up in acute promyelocytic leukemia", BLOOD, 98(9), 2001, pp. 2651-2656
16. Douer, D; Estey, E; Santillana, S; Bennett, JM; Lopez-Bernstein, G; Boehm, K; Williams, T
    Treatment of newly diagnosed and relapsed acute promyelocytic leukemia with intravenous liposomal all-trans retinoic acid
    BLOOD
    
    D. Douer et al., "Treatment of newly diagnosed and relapsed acute promyelocytic leukemia with intravenous liposomal all-trans retinoic acid", BLOOD, 97(1), 2001, pp. 73-80
17. Lengfelder, E; Hehlmann, R; Buchner, T
    Current therapeutic concept of acute promyelocytic leukaemia
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    
    E. Lengfelder et al., "Current therapeutic concept of acute promyelocytic leukaemia", DEUT MED WO, 126(39), 2001, pp. 1073-1079
18. Barrett, AJ
    Conditioning regimens for allogeneic stem cell transplants
    CURRENT OPINION IN HEMATOLOGY
    
    A.J. Barrett, "Conditioning regimens for allogeneic stem cell transplants", CURR OPIN H, 7(6), 2000, pp. 339-342
19. Bendandi, M
    Anti-idiotype vaccines for human follicular lymphoma
    LEUKEMIA
    
    M. Bendandi, "Anti-idiotype vaccines for human follicular lymphoma", LEUKEMIA, 14(8), 2000, pp. 1333-1339
20. Lengfelder, E; Reichert, A; Schoch, C; Haase, D; Haferlach, T; Loffler, H; Staib, P; Heyll, A; Seifarth, W; Saussele, S; Fonatsch, C; Gassmann, W; Ludwig, WD; Hochhaus, A; Beelen, D; Aul, C; Sauerland, MC; Heinecke, A; Hehlmann, R; Wormann, B; Hiddemann, W; Buchner, T
    Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia
    LEUKEMIA
    
    E. Lengfelder et al., "Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia", LEUKEMIA, 14(8), 2000, pp. 1362-1370
21. Sanz, MA; Larrea, L; Sanz, GF; Martin, G; Sempere, A; Gomis, F; Martinez, JA; Regadera, A; Saavedra, S; Jarque, I; Jimenez, C; Cervera, J; de la Rubia, J
    Cutaneous promyelocytic sarcoma at sites of Vascular access and marrow aspiration. A characteristic localization of chloromas in acute promyelocytic leukemia?
    HAEMATOLOGICA
    
    M.A. Sanz et al., "Cutaneous promyelocytic sarcoma at sites of Vascular access and marrow aspiration. A characteristic localization of chloromas in acute promyelocytic leukemia?", HAEMATOLOG, 85(7), 2000, pp. 758-762
22. Zinzani, PL; Bendandi, M; Gamberi, B; Magagnoli, M; Gherlinzoni, F; Tura, S
    Complete molecular remission induced by rituximab in a patient with diffuse large cell lymphoma
    HAEMATOLOGICA
    
    P.L. Zinzani et al., "Complete molecular remission induced by rituximab in a patient with diffuse large cell lymphoma", HAEMATOLOG, 85(4), 2000, pp. 437-438
23. Hu, J; Yu, T; Zhao, WL; Gu, BW; Shen, ZX; Li, XS; Sun, GL; Chen, SJ; Wang, ZY
    Impact of RT-PCR monitoring on the long-term survival in acute promyelocytic leukemia
    CHINESE MEDICAL JOURNAL
    
    J. Hu et al., "Impact of RT-PCR monitoring on the long-term survival in acute promyelocytic leukemia", CHIN MED J, 113(10), 2000, pp. 899-902
24. Weil, SC
    Minimal residual disease in acute promyelocytic leukemia
    CLINICS IN LABORATORY MEDICINE
    
    S.C. Weil, "Minimal residual disease in acute promyelocytic leukemia", CLIN LAB M, 20(1), 2000, pp. 105
25. Zhang, JW; Gu, J; Wang, ZY; Chen, SJ; Chen, Z
    Mechanisms of all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells
    JOURNAL OF BIOSCIENCES
    
    J.W. Zhang et al., "Mechanisms of all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells", J BIOSCI, 25(3), 2000, pp. 275-284
26. de Botton, S; Chevret, S; Sanz, M; Dombret, H; Thomas, X; Guerci, A; Fey, M; Rayon, C; Huguet, F; Sotto, JJ; Gardin, C; Makhoul, PC; Travade, P; Solary, E; Fegueux, N; Bordessoule, D; San Miguel, J; Link, H; Desablens, B; Stamatoullas, A; Deconinck, E; Geiser, K; Hess, U; Maloisel, F; Castaigne, S; Preudhomme, C; Chomienne, C; Degos, L; Fenaux, P
    Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial
    BRITISH JOURNAL OF HAEMATOLOGY
    
    S. de Botton et al., "Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial", BR J HAEM, 111(3), 2000, pp. 801-806
27. Barrett, J; Childs, R
    Non-myeloablative stem cell transplants
    BRITISH JOURNAL OF HAEMATOLOGY
    
    J. Barrett e R. Childs, "Non-myeloablative stem cell transplants", BR J HAEM, 111(1), 2000, pp. 6-17
28. Sanz, MA; Martinez, JA; Barragan, E; Martin, G; Lo Coco, F
    All-trans retinoic acid and low-dose chemotherapy for acute promyelocytic leukaemia
    BRITISH JOURNAL OF HAEMATOLOGY
    
    M.A. Sanz et al., "All-trans retinoic acid and low-dose chemotherapy for acute promyelocytic leukaemia", BR J HAEM, 109(4), 2000, pp. 896-897
29. Foran, JM; Gupta, RK; Cunningham, D; Popescu, RA; Goldstone, AH; Sweetenham, JW; Pettengell, R; Johnson, PWM; Bessell, E; Hancock, B; Summers, K; Hughes, J; Rohatiner, AZS; Lister, TA
    A UK multicentre phase II study of rituximab (chimaeric anti-CD20 monoclonal antibody) in patients with follicular lymphoma, with PCR monitoring of molecular response
    BRITISH JOURNAL OF HAEMATOLOGY
    
    J.M. Foran et al., "A UK multicentre phase II study of rituximab (chimaeric anti-CD20 monoclonal antibody) in patients with follicular lymphoma, with PCR monitoring of molecular response", BR J HAEM, 109(1), 2000, pp. 81-88
30. Sanz, MA; Lo Coco, F; Martin, G; Avvisati, G; Rayon, C; Barbui, T; Diaz-Mediavilla, J; Fioritoni, G; Gonzalez, JD; Liso, V; Esteve, J; Ferrara, F; Bolufer, P; Bernasconi, C; Gonzalez, M; Rodeghiero, F; Colomer, D; Petti, MC; Ribera, JM; Mandelli, F
    Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups
    BLOOD
    
    M.A. Sanz et al., "Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups", BLOOD, 96(4), 2000, pp. 1247-1253
31. Tarella, C; Corradini, P; Astolfi, M; Bondesan, P; Caracciolo, D; Cherasco, C; Ladetto, M; Giaretta, F; Ricca, I; Vitolo, U; Pileri, A; Ferrero, D
    Negative immunomagnetic ex vivo purging combined with high-dose chemotherapy with peripheral blood progenitor cell autograft in follicular lymphoma patients: evidence for long-term clinical and molecular remissions
    LEUKEMIA
    
    C. Tarella et al., "Negative immunomagnetic ex vivo purging combined with high-dose chemotherapy with peripheral blood progenitor cell autograft in follicular lymphoma patients: evidence for long-term clinical and molecular remissions", LEUKEMIA, 13(9), 1999, pp. 1456-1462
32. Au, WY; Lie, AKW; Lee, CK; Liang, R; Kwong, YL
    Donor lymphocyte infusion induced molecular remission in relapse of acute myeloid leukaemia after allogeneic bone marrow transplantation
    BONE MARROW TRANSPLANTATION
    
    W.Y. Au et al., "Donor lymphocyte infusion induced molecular remission in relapse of acute myeloid leukaemia after allogeneic bone marrow transplantation", BONE MAR TR, 23(11), 1999, pp. 1201-1203
33. IRVING JAE; FINNEY R; LENNARD A; PROCTOR SJ
    MOLECULAR REMISSION IN PHILADELPHIA-POSITIVE ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA RAPIDLY INDUCED BY CONVENTIONAL-DOSE CHEMOTHERAPY
    Bone marrow transplantation
    
    J.A.E. Irving et al., "MOLECULAR REMISSION IN PHILADELPHIA-POSITIVE ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA RAPIDLY INDUCED BY CONVENTIONAL-DOSE CHEMOTHERAPY", Bone marrow transplantation, 21(3), 1998, pp. 323-325
34. CARELLA AM; LERMA E; CORSETTI MT; DEJANA A; CELESTI L; CASARINO L; DESTEFANO F; FRASSONI F
    EVIDENCE OF CYTOGENETIC AND MOLECULAR REMISSION BY ALLOGENEIC CELLS AFTER IMMUNOSUPPRESSIVE THERAPY ALONE
    British Journal of Haematology
    
    A.M. Carella et al., "EVIDENCE OF CYTOGENETIC AND MOLECULAR REMISSION BY ALLOGENEIC CELLS AFTER IMMUNOSUPPRESSIVE THERAPY ALONE", British Journal of Haematology, 103(2), 1998, pp. 565-567
35. RAANANI P; DAZZI F; SOHAL J; SZYDLO RM; VANRHEE F; REITER A; LIN F; GOLDMAN JM; CROSS NCP
    THE RATE AND KINETICS OF MOLECULAR RESPONSE TO DONOR LEUKOCYTE TRANSFUSIONS IN CHRONIC MYELOID-LEUKEMIA PATIENTS TREATED FOR RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    British Journal of Haematology
    
    P. Raanani et al., "THE RATE AND KINETICS OF MOLECULAR RESPONSE TO DONOR LEUKOCYTE TRANSFUSIONS IN CHRONIC MYELOID-LEUKEMIA PATIENTS TREATED FOR RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION", British Journal of Haematology, 99(4), 1997, pp. 945-950
36. YANO K; IIJIMA K; SAO H; KOBAYASHI M
    MOLECULAR REMISSION ACHIEVED BY INTERFERON THERAPY IN A PATIENT WITH CYTOGENETICALLY RELAPSED CHRONIC MYELOGENOUS LEUKEMIA AFTER SYNGENEIC BONE-MARROW TRANSPLANTATION
    International journal of hematology
    
    K. Yano et al., "MOLECULAR REMISSION ACHIEVED BY INTERFERON THERAPY IN A PATIENT WITH CYTOGENETICALLY RELAPSED CHRONIC MYELOGENOUS LEUKEMIA AFTER SYNGENEIC BONE-MARROW TRANSPLANTATION", International journal of hematology, 64(3-4), 1996, pp. 267-270
37. LADETTO M; CORRADINI P; ASTOLFI M; CAMPANA S; TARELLA C; PILERI A
    LONG-TERM MOLECULAR REMISSION AFTER CONVENTIONAL CHEMOTHERAPY IN A PATIENT WITH PHILADELPHIA-NEGATIVE ACUTE LYMPHOBLASTIC-LEUKEMIA
    Haematologica
    
    M. Ladetto et al., "LONG-TERM MOLECULAR REMISSION AFTER CONVENTIONAL CHEMOTHERAPY IN A PATIENT WITH PHILADELPHIA-NEGATIVE ACUTE LYMPHOBLASTIC-LEUKEMIA", Haematologica, 81(2), 1996, pp. 159-161
38. WAKUI M; OKAMOTO S; ISHIDA A; TANOSAKI R; MORI T; KAWAI Y; OHSHIMA S; IKEDA Y
    DURABLE MOLECULAR REMISSION IN A PATIENT WITH CHRONIC MYELOGENOUS LEUKEMIA AND HOST-DERIVED HEMATOPOIESIS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    Bone marrow transplantation
    
    M. Wakui et al., "DURABLE MOLECULAR REMISSION IN A PATIENT WITH CHRONIC MYELOGENOUS LEUKEMIA AND HOST-DERIVED HEMATOPOIESIS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION", Bone marrow transplantation, 18(4), 1996, pp. 801-804
39. ITO Y; MIYAMURA K
    CLINICAL-SIGNIFICANCE OF MINIMAL RESIDUAL DISEASE IN LEUKEMIA DETECTED BY POLYMERASE CHAIN-REACTION - IS MOLECULAR REMISSION A MILESTONE FOR ACHIEVING A CURE
    Leukemia & lymphoma
    
    Y. Ito e K. Miyamura, "CLINICAL-SIGNIFICANCE OF MINIMAL RESIDUAL DISEASE IN LEUKEMIA DETECTED BY POLYMERASE CHAIN-REACTION - IS MOLECULAR REMISSION A MILESTONE FOR ACHIEVING A CURE", Leukemia & lymphoma, 16(1-2), 1994, pp. 57-64
40. LEBER B; WALKER IR; RODRIGUEZ A; MCBRIDE JA; CARTER R; BRAIN MC
    REINDUCTION OF REMISSION OF CHRONIC MYELOID-LEUKEMIA BY DONOR LEUKOCYTE TRANSFUSION FOLLOWING RELAPSE AFTER BONE-MARROW TRANSPLANTATION - RECOVERY COMPLICATED BY INITIAL PANCYTOPENIA AND LATE DERMATOMYOSITIS
    Bone marrow transplantation
    
    B. Leber et al., "REINDUCTION OF REMISSION OF CHRONIC MYELOID-LEUKEMIA BY DONOR LEUKOCYTE TRANSFUSION FOLLOWING RELAPSE AFTER BONE-MARROW TRANSPLANTATION - RECOVERY COMPLICATED BY INITIAL PANCYTOPENIA AND LATE DERMATOMYOSITIS", Bone marrow transplantation, 12(4), 1993, pp. 405-407